Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 17 Mar 2023 for CENTENE CORP, €28k. Read the official filing
Filing timeline
BuySaleJames e. Murray
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-8.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
James e. Murray: trading record in brief
James e. Murray, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Centene Corp and Magellan Health Inc. Over a trading history stretching from 2 January 2022 to 15 March 2023, the count stands at 3 filings.
The open-market record is one-sided, with 1 purchase worth €461k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant and 1 option exercise. In 2023 alone, the filings show 1 purchase and no sales.
On 17 March 2023 came the latest disclosure, a share grant for €28k in Centene Corp. The most recent open-market purchase was published on 9 February 2023, 1,347 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to James e. Murray
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
466 shares@ US$63.345.6% of flowCommon StockSEC:0001071739-23-000071:0
6,750 shares@ US$73.3094.4% of flowCommon StockSEC:0001071739-23-000030:0
Canonical exit: 9 May 2023 (T+90)
3,262 sharesOrdinary Common Stock, $0.01 par valueSEC:0001209191-22-000998:0
3 of 3 declarations
